Patents by Inventor Pek Yoke Chong

Pek Yoke Chong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemical Compounds
    Publication number: 20220144834
    Abstract: Compounds, specifically hepatitis B virus and/or hepatitis D virus inhibitors, more specifically compounds that inhibit HBe antigen and HBs antigen in a subject, for the treatment of viral infections, and methods of preparing and using such compounds.
    Type: Application
    Filed: October 25, 2021
    Publication date: May 12, 2022
    Inventors: John G. CATALANO, Pek Yoke CHONG, Hamilton D. DICKSON, Martin R. LEIVERS, Jason Gordon WEATHERHEAD
  • CHEMICAL COMPOUNDS
    Publication number: 20200255428
    Abstract: Compounds, specifically hepatitis B virus and/or hepatitis D virus inhibitors, more specifically compounds that inhibit HBe antigen and HBs antigen in a subject, for the treatment of viral infections, and methods of preparing and using such compounds.
    Type: Application
    Filed: October 5, 2018
    Publication date: August 13, 2020
    Applicant: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: John G. CATALANO, Pek Yoke CHONG, Hamilton D. DICKSON, Martin R. LEIVERS, Jason Gordon WEATHERHEAD
  • Modulators of indoleamine 2,3-dioxygenase
    Patent number: 10472336
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: November 12, 2019
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Pek Yoke Chong, Martha Alicia De La Rosa, Hamilton D. Dickson, Wieslaw Mieczyslaw Kazmierski, Vicente Samano, Vincent Wing-Fai Tai
  • Modulators of indoleamine 2,3-dioxygenase
    Patent number: 10358427
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: July 23, 2019
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Pek Yoke Chong, Martha Alicia De La Rosa, Hamilton D. Dickson, Wieslaw Mieczyslaw Kazmierski, Vicente Samano, Vincent Wing-Fai Tai
  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20190040023
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression.
    Type: Application
    Filed: September 22, 2016
    Publication date: February 7, 2019
    Inventors: Pek Yoke CHONG, Martha Alicia DE LA ROSA, Hamilton D DICKSON, Wieslaw Mieczyslaw KAZMIERSKI, Vicente SAMANO, Vincent Wing-Fai TAI
  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20180290988
    Abstract: This invention is directed to photoluminescent compounds based on rhodamine dyes with green emission and uses thereof for photoluminescence based devices.
    Type: Application
    Filed: September 22, 2016
    Publication date: October 11, 2018
    Inventors: Pek Yoke CHONG, Martha Alicia DE LA ROSA, Hamilton D. DICKSON, Wieslaw Mieczyslaw KAZMIERSKI, Vicente SAMANO, Vincent Wing-Fai TAI
  • Benzofuran compounds for the treatment of hepatitis C virus infections
    Patent number: 9682999
    Abstract: The present invention features compounds of formula (I): and salts thereof, pharmaceutical compositions comprising said compounds, and uses of such compounds in treating or preventing viral infections, such as HCV infections, and diseases associated with such infections.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: June 20, 2017
    Assignee: Glaxo Group Limited
    Inventors: Pek Yoke Chong, John F. Miller, Andrew James Peat, John Brad Shotwell
  • Benzofuran Compounds For The Treatment Of Hepatitis C Virus Infections
    Publication number: 20150080343
    Abstract: The present invention features compounds of formula (I): and salts thereof, pharmaceutical compositions comprising said compounds, and uses of such compounds in treating or preventing viral infections, such as HCV infections, and diseases associated with such infections.
    Type: Application
    Filed: November 20, 2014
    Publication date: March 19, 2015
    Inventors: Pek Yoke Chong, John F. Miller, Andrew James Peat, John Brad Shotwell
  • Benzofuran compounds for the treatment of hepatitis C virus infections
    Patent number: 8927593
    Abstract: The present invention features compounds of formula (I): and salts thereof, pharmaceutical compositions comprising said compounds, and uses of such compounds in treating or preventing viral infections, such as HCV infections, and diseases associated with such infections.
    Type: Grant
    Filed: August 10, 2012
    Date of Patent: January 6, 2015
    Assignee: Glaxo Group Limited
    Inventors: Pek Yoke Chong, John Brad Shotwell
  • Benzofuran Compounds For The Treatment Of Hepatitis C Virus Infections
    Publication number: 20130237501
    Abstract: The present invention features compounds of formula (I): and salts thereof, pharmaceutical compositions comprising said compounds, and uses of such compounds in treating or preventing viral infections, such as HCV infections, and diseases associated with such infections.
    Type: Application
    Filed: August 10, 2012
    Publication date: September 12, 2013
    Applicant: Glaxo Group Limited
    Inventors: Pek Yoke Chong, John F. Miller, Andrew James Peat, John Brad Shotwell
  • Chemical compounds
    Patent number: 8304419
    Abstract: The present invention relates to compounds that are a non-nucleoside reverse transcriptase inhibitors, and to processes for the preparation and use of the same. Specifically, the present invention includes methods of using such compounds in the treatment of human immunodeficiency virus infection.
    Type: Grant
    Filed: June 5, 2008
    Date of Patent: November 6, 2012
    Assignee: GlaxoSmithKline LLC
    Inventors: Pek Yoke Chong, Andrew James Peat, Paul Richard Sebahar, Michael Youngman, Huichang Zhang
  • CHEMICAL COMPOUNDS
    Publication number: 20100216746
    Abstract: The present invention relates to compounds that are a non-nucleoside reverse transcriptase inhibitors, and to processes for the preparation and use of the same. Specifically, the present invention includes methods of using such compounds in the treatment of human immunodeficiency virus infection.
    Type: Application
    Filed: June 5, 2008
    Publication date: August 26, 2010
    Applicant: GLAXOSMITHKLINE LLC
    Inventors: PEK Yoke Chong, Andrew James Peat, Paul Richard Sebahar, Michael Youngman, Huichang Zhang
  • CCR5 antagonists as therapeutic agents
    Patent number: 7645771
    Abstract: The present invention relates to compounds of formula (I) or a pharmaceutically acceptable derivatives thereof, useful in the treatment of prophylazis of CCR5-related diseases and disorders, for example, in the inhibition of HIV replication, the prevention or treatment of HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).
    Type: Grant
    Filed: December 12, 2003
    Date of Patent: January 12, 2010
    Assignee: SmithKline Beecham Corp.
    Inventors: Wieslaw Mieczyslaw Kazmierski, Chrisopher Joseph Aquino, Neil Bifulco, Eric Eugene Boros, Brian Andrew Chauder, Pek Yoke Chong, Maosheng Duan, Felix Deanda, Jr., Cecilia Suarez Koble, Ed Williams McLean, Jennifer Poole Peckham, Angilique C Perkins, James Benjamin Thompson, Dana Vanderwall
  • HETEROCYCLIC COMPOUNDS AS CCR5 ANTAGONISTS
    Publication number: 20090053172
    Abstract: The present invention relates to compounds of formula (I), or pharmaceutically acceptable derivatives thereof, useful in the treatment of CCR5-related diseases and disorders, for example, useful in the inhibition of HIV replication, the prevention or treatment of an HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).
    Type: Application
    Filed: October 15, 2008
    Publication date: February 26, 2009
    Inventors: Christopher Joseph AQUINO, Pek Yoke CHONG, Maosheng DUAN, Wieslaw Mieczyslaw KAZMIERSKI